ESMO Pocket Guidelines & Mobile App

Our mobile library App: "ESMO Cancer Guidelines" is compatible with Android, iPhone and iPad, and features ten titles – each one providing the essential recommendations from all CPG on a specific topic.

Printed copies of the Pocket Guidelines are distributed during ESMO events. The full ESMO Clinical Practice Guidelines (CPG) are published in Annals of Oncology.

ESMO Clinical Practice Guidelines (CPG) focus on the best standards of cancer care. They are developed by groups of expert authors who formulated recommendations based on evidence-based medicine.

Download the App now!

ESMO Pocket Guideline App Google QR

Scan QR code to download on your device

Or download here: 

Breast Cancer

ESMO Pocket Guidelines: Breast Cancer

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for primary, locally recurrent and metastatic breast cancer. and also include a section on BRCA in breast cancer.

Updated version: published September 2013

Head and Neck Cancer

ESMO Pocket Guidelines 2013 Head and Neck Cancer

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for head and neck cancer (HSNCC) They also include a section on nasopharyngeal cancer.

New: published September 2013

Gynaecological Malignancies

ESMO pocket guidelines: gynaecological malignancies

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for newly diagnosed and relapsed epithelial ovarian carcinoma, non-epithelial ovarian cancer, cervical cancer, endometrial cancer and gestational trophoblastic disease.

New: published September 2013

Lower Gastrointestinal Cancers

ESMO pocket guidelines: lower GI

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for early colon cancer, familial colorectal cancer [CRC] risk, rectal cancer, anal cancer and advanced CRC.

New: published September 2013

 

Lung Cancer

ESMO Pocket Guidelines: Lung Cancer cover

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for early-stage, locally advanced and metastatic non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). They also include a section on malignant pleural mesothelioma.

Updated version: published September 2013

Upper Gastrointestinal Cancers

ESMO pocket guidelines: upper GI

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendation for oesophageal cancer, gastric cancer, biliary cancer, hepatocellular carcinoma and pancreatic adenocarcinoma.

New: published September 2013

Urogenital Cancer

ESMO Pocket Guidelines: Urogenital Cancer cover

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendations for prostate cancer, bladder cancer, renal cell carcinoma, testicular seminoma and non-seminoma and also include the new ESMO recommendations for penile cancer.

Updated version: published September 2013

NETs and GIST

ESMO Pocket Guidelines: NETs & GIST cover

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendations for thyroid cancer, neuroendocrine bronchial and thymic tumours, adrenal cancer, neuroendrocrine gastro-pancreatic tumours and gastrointestinal stromal tumours (GIST). The GIST guidelines were developed during an ESMO Consensus Conference held in January 2012.

Published September 2012

Sarcoma

ESMO Pocket Guidelines:Sarcoma cover

These Pocket Guidelines summarise diagnosis, treatment and follow-up recommendations for both Soft Tissue Sarcomas (STS) and Bone Sarcomas. These guidelines were developed during an ESMO Consensus Conference held in January 2012.

Published September 2012

Supportive Care

ESMO Pocket Guidelines: Supportive Care cover

These Pocket Guidelines summarise recommendations for:  the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting; erythropoiesis-stimulating agents in the treatment of anaemia; applications of haematopoietic growth factors; management of  febrile neutropenia, cancer pain, oral and gastrointestinal mucositis, venous thromboembolism (VTE), cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy; cancer, fertility and pregnancy; and chemotherapy extravasation.

Published September 2012